Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
The present invention provides compounds of Formula (I): or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors. 
Bristol-Myers Squibb Company
A C A C A C A C A C
A61P C07C A61P C07D A61P C07D A61P C07C A61P C07D
additional inventional inventional inventional additional inventional additional inventional additional inventional
Yan James R. Jun Jun Robert F. Lawrence J. Ying Shiwei Peter Tai Wah Hao
Shi Corte Li Shi Kaltenbach, III Kennedy Wang Tao Cheng Zhang